Nathaniel Calloway - Nov 1, 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Nov 1, 2022
Transactions value $
$0
Form type
4
Date filed
11/2/2022, 04:31 PM
Previous filing
Nov 2, 2022
Next filing
Jan 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +59.1K $0.00 59.1K Nov 1, 2022 Common Stock 59.1K $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares vest on the first anniversary of November 1, 2022 (the "Vesting Commencement Date") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date.